Atlas Trials

Tocilizumab for Chronic Graft-versus-Host Disease Treatment

Clinical trial NCT02174263 · WITHDRAWN

Trial details

NCT number
NCT02174263
Sponsor
Fred Hutchinson Cancer Center
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Graft Versus Host Disease
Start date
2016-02-01
Primary completion
2019-08-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.